My Cart

Biotinylated Human SLAMF7 / CRACC / CD319 Protein, Avitag™,His Tag (MALS verified)

Cat. No. / Size
Price
Qty
SL7-H82E0-25ug
$360.00
SL7-H82E0-200ug
$1565.00
ETA of in-stock products:2 business days
Sub-Total$ 0

Product Details

  • Synonyms

    SLAMF7, CD319, CS1, CRACC, 19A, FOAP-12

  • Source

    Biotinylated Human SLAMF7, Avitag,His Tag (SL7-H82E0) is expressed from human 293 cells (HEK293). It contains AA Ser 23 - Met 226 (Accession # Q9NQ25-1).

    Predicted N-terminus: Ser 23

    Request for sequence
  • Molecular Characterization

    SLAMF7 Structure

    Other Tags and Version Biotin & Other Labeled Version

    This protein carries an Avi tag (Avitag™) at the C-terminus, followed by a polyhistidine tag.

    The protein has a calculated MW of 25.6 kDa. The protein migrates as 35-50 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE) due to glycosylation.

  • Labeling

    Biotinylation of this product is performed using Avitag™ technology. Briefly, the single lysine residue in the Avitag is enzymatically labeled with biotin.

  • Protein Ratio

    Passed as determined by the HABA assay / binding ELISA.

  • Endotoxin

    Less than 0.1 EU per μg by the LAL method / rFC method.

  • Purity

    >95% as determined by SDS-PAGE.

    >95% as determined by SEC-MALS.

  • Formulation

    Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.

    Contact us for customized product form or formulation.

  • Reconstitution

    Please see Certificate of Analysis for specific instructions.

    For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

  • Shipping and Storage

    This product is shipped at ambient temperature.

    For long term storage, the product should be stored at lyophilized state at -20°C or lower.

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. -20°C to -70°C for 12 months in lyophilized state;
    2. -70°C for 3 months under sterile conditions after reconstitution.
  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

Customers Also Viewed

Performance Data

  • SDS-PAGE

    SLAMF7 SDS-PAGE

    Biotinylated Human SLAMF7, Avitag,His Tag on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 95% (With Star Ribbon Pre-stained Protein Marker).

  • SEC-MALS

    SLAMF7 SEC-MALS

    The purity of Biotinylated Human SLAMF7, Avitag,His Tag (Cat. No. SL7-H82E0) is more than 95% and the molecular weight of this protein is around 45-60 kDa verified by SEC-MALS.

    Report
  • Bioactivity-ELISA

     SLAMF7 ELISA

    Immobilized Anti-SLAMF7/CS1 Antibody, Human IgG1 at 1 μg/mL (100 μL/well) can bind Biotinylated Human SLAMF7, Avitag,His Tag (Cat. No. SL7-H82E0) with a linear range of 0.2-2 ng/mL (QC tested).

    Protocol
  •  SLAMF7 ELISA

    Immobilized Humanized Anti-Human CS1 MAb at 1 μg/mL (100 μL/well) can bind Biotinylated Human SLAMF7, Avitag,His Tag (Cat. No. SL7-H82E0) with a linear range of 0.6-5 ng/mL (Routinely tested).

    Protocol
  • Bioactivity-FACS

     SLAMF7 FACS

    2e5 of Anti-SLAMF7 CAR-293 cells were stained with 100 μL of 0.1 μg/mL of Biotinylated Human SLAMF7, Avitag, His Tag (Cat. No. SL7-H82E0) and negative control protein respectively, washed and then followed by PE-SA and analyzed with FACS (QC tested).

    Protocol

Customer Reviews
Writing Reviews

Background

SLAM family member 7 (SLAMF7) is also known as CD2-like receptor-activating cytotoxic cells (CRACC), Membrane protein FOAP-12, CD antigen CD319, Novel Ly9, Protein 19A, which is a single-pass type I membrane protein and a member of the CD2 family of cell surface receptors. SLAMF7 is expressed in spleen, lymph node, peripheral blood leukocytes, bone marrow, small intestine, stomach, appendix, lung and trachea. Isoform 1 of SLAMF7 mediates NK cell activation through a SH2D1A-independent extracellular signal-regulated ERK-mediated pathway. May play a role in lymphocyte adhesion. Isoform 3 of SLAMF7 does not mediate any NK cell activation.

Recent Advances

 
Drug Development Progress
  • English Name:

    SLAM family member 7

  • Category:

  • Approved Drugs:

    1 Details

  • Drugs in Clinical Trials:

    8 Details

  • Highest Development Stage:

    Approved

Contact Us
Drug Candidate Licensing
More
  • Basic Product Information
  • Product Details
  • Customers Also Viewed
  • Performance Data
  • Customer Reviews
  • Background
Contact Us

[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521

[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland